Corvus Pharmaceuticals, Inc. - CRVS
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Richard A. Miller | 7.8% | 6,085,922 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 | 1.6% | 1,188,103 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Sandra J. Horning | 1.6% | 1,188,103 | View |
| Feb 05, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Jan 30, 2026 | SCHEDULE 13G | The Vanguard Group | 5.18% | 3,873,482 | View |
| Jan 27, 2026 | SCHEDULE 13D/A | — | 1.0% | 8,609,091 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.